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Abstract
Recent and substantial changes in access to restricted medicines by podiatrists in Australia are
clearly consistent with healthcare policies aimed at reshaping the healthcare workforce. At the
same time, prescribing and access to medicines by allied health professionals, including podiatrists,
has been the focus of a recent scoping project by the UK Department of Health. In this
commentary we explore the possible implications of these changes.
Background
Non-medical prescribing has been viewed as a challeng-
ing transition in professional role boundaries, as well as a
necessary component of workforce redesign essential to
the creation of a sustainable health service [1-3]. There is
little doubt that the need for non-medical healthcare pro-
fessionals to assume new roles, including those previously
exclusive to the medical profession, constitutes part of the
drive towards long-term sustainability and affordability in
health care provision across the Western world. In such a
climate, change may be inevitable, but it has certainly not
been effortless. As Britten [4] has pointed out, prescribing
remains "one of the core activities that demarcate the
medical profession from other groups...", indicating the
extent to which workforce 'flexibility' impacts on 'tradi-
tional' role boundaries.
Clearly, non-medical prescribing has emerged as a result
of healthcare policies seeking to address pressing demo-
graphic and economic concerns [5,6], and these impera-
tives continue to drive forward the 'extended scope'
agenda. Podiatric prescribing is one such example, as well
as an exemplar illustrating the difficulties posed in trans-
ferring role responsibilities from one profession to
another [2]. Understanding the contemporary context of
these changes is dependent upon an appreciation of the
complex socio-historical developments which preceded
them, and the paper by Borthwick et al, recently published
in Journal of Foot and Ankle Research, may be used as a
yardstick for judging the progress made over many years
[7]. In this commentary, however, the authors focus on
two of the most recent events, and consider what these
may mean for future practice.
Recent developments in the UK
In July of 2009 the UK Department of Health published a
report on the recent scoping project undertaken to re-
examine the case for enhanced access rights to medicines
by the allied health professions [8]. Whilst the focus of the
study was to reconsider the utility and applicability of all
existing mechanisms for accessing restricted category
medicines, the final recommendations are worthy of com-
ment, because they assert that there is a 'strong case for
progression to independent prescribing' by podiatrists
and physiotherapists [8]. It also suggests further funded
exploratory research to inform how these key recommen-
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dations can be taken forward. It may even be fair to sug-
gest that it is an indication of the extent to which the
Department of Health now considers the prescribing of
medicines by allied health professionals to be a safe and
effective use of resources in answer to the growing needs
of patients and their health service providers, both in
terms of responsiveness and adaptability.
The challenge for the profession of podiatry will be to
ensure that sufficient numbers of practitioners undertake
the additional training and education necessary to carry
out these tasks, and to ensure that these skills are fully uti-
lised in practice. Although podiatric surgeons already pos-
sess the necessary training and skills, and would
undoubtedly benefit from early recognition as independ-
ent prescribers, other services would also benefit from this
enhanced scope - such as podiatrists specialising in dia-
betic foot care, where, for example, a rapid response to
foot infections is critical [9]. As 'supplementary' prescrib-
ers, many already do. Yet practitioners working in general
practice should not view themselves as excluded from
these roles, and must also consider the contribution that
they can make to ensuring the provision of healthcare fit
for purpose in the 21st century.
Clearly, the Department of Health has taken another sig-
nificant step, reflecting the current health policy direction
and a recognition of the advances in allied health clinical
practice. Policy development leading to further regulatory
change and eventual implementation is, however, likely
to be a slow process, if the Australian experience is to be
considered a guide.
Recent developments in Australia
The extension of prescribing rights for non-medical prac-
titioners in Australia has been problematic; in part due to
the structural complexity of the Australian health care sys-
tem. Whereas the UK health professions have one registra-
tion authority, providing a uniform approach to
regulation, Australia has eight states and territories, each
with separate legislation for both professional and 'poi-
sons' regulation. This is complicated further by current
funding arrangements, which operate on a complex pub-
lic and private system model in which funding for services
provided by medical practitioners take precedence and
services provided by non medical practitioners is limited.
A further barrier to access is the cost of restricted medi-
cines which are subsidised under the Pharmaceutical Ben-
efits Scheme (PBS). The PBS does not automatically
extend to non medical prescribers. It is not, then, merely
a question of regulation - it is inclusion within the PBS
that is necessary if patients are to be treated equally. The
position of podiatric surgery in Australia reflects the
impact that inequity with funding can have. Australian
podiatric surgeons (the first podiatrists to gain prescribing
rights in Australia) face significant barriers to providing a
full contribution to the health workforce [10]. This is
despite broad recognition of the need for role flexibility
[11-13].
Against the backdrop of these structural difficulties, the
Victorian podiatry profession (approximately 1/3 of the
podiatric profession in Australia) was recently granted an
extension of scope of practice to include prescription of
restricted medicines. The Victorian legislation (Health
Practitioners Act 2005) acknowledges podiatrists as pre-
scribers of restricted substances. Implementation is pro-
gressing such that all graduate podiatrists are now able to
be endorsed to prescribe (after completion of the endorse-
ment process) a broad range of clinically appropriate
restricted medicines. The first podiatrists with these rights
are expected to be endorsed by the Podiatrists Registration
Board of Victoria by the end of 2009.
The imminent arrival of a new national board for all
health professionals, in July 2010, promises to ensure a
high degree of uniformity (at least in principle) [14]. Ini-
tially within this scheme (as far as medicines are con-
cerned) individual state poisons regulations will still
apply, which will delay Australia-wide application of the
Victorian reform agenda. Indeed, it is yet to be determined
whether the Victorian model will be adopted as a
National framework by the new National Podiatry Board.
Discussion
In Victoria, the co-operative approach to reform demon-
strated by the regulatory body (registration board), educa-
tional institutions, professional bodies and government
departments has demonstrated what can be achieved. The
process, however, took over 15 years, involving extensive
stakeholder engagement and curriculum reform.
The result is that Victorian podiatrists are now provided,
at a graduate level, with a sufficient grounding in the med-
ical sciences to register as health practitioners able to pre-
scribe restricted medicines.
The reform in Victoria sets a new benchmark for Austral-
ian podiatric education and scope of practice. There are
significant long term and broader implications for the
position of podiatry in the Australian health sector. It is
acknowledged that there is sufficient clinical need and
appropriate educational background to enable the pre-
scribing of restricted pharmacological agents by podia-
trists. Importantly, this acknowledgment is not confined
to particular specialist areas of practice (such as surgery) -
which represents a paradigm shift.
Given the timeframe for reform and implementation
observed in Victoria, it will be of interest to monitor thePublish with BioMed Central    and   every 
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speed of further reform in the UK. It is intriguing to con-
sider how "a strong case for independent prescribing"
might be translated into practice and if it will resemble the
developments in Victoria. In Australia, ongoing interest
will relate to how the Victorian model will affect the
national scene, but with the emergence of a national reg-
istration board it is possible that this approach will be
endorsed by a national podiatry board, and that local state
jurisdictions will seek to amend their poisons regulations
accordingly. Funding imbalances are likely to be
addressed only when a uniform and National approach to
prescribing is in place. For those interested in how the
new rights should work in practice, it would be worth
viewing the website of the Podiatrists Registration Board
of Victoria, where a section is devoted to the recent S4
issue [15].
In summary, non-medical prescribing is a pragmatic and
workable solution to a major challenge facing health serv-
ices across the Western world. Even now it appears to be
proving its worth, increasing the rate at which health care
practitioners are utilised for skill sets rather than governed
by lines of demarcation.
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